Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 7366 to 7380 of 8314 results

  1. Favezelimab–pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after anti-PD-L1 treatment [ID6393]

    In development Reference number: GID-TA11486 Expected publication date: TBC

    Technology appraisal guidance
    In development

  2. Nivolumab with docetaxel for treating hormone-relapsed advanced prostate cancer after 1 or 2 hormonal therapies [ID4048]

    Discontinued Reference number: GID-TA10929

    Technology appraisal guidance
    Discontinued

  3. Nivolumab for adjuvant treatment of localised renal cell carcinoma [ID6362]

    Discontinued Reference number: GID-TA11421

    Technology appraisal guidance
    Discontinued

  4. Tazemetostat for treating relapsed or refractory follicular lymphoma after 2 or more treatments [ID6349]

    Discontinued Reference number: GID-TA11399

    Technology appraisal guidance
    Discontinued

  5. Docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer (TA26)

    This guidance has been replaced by NICE guideline CG24 [Replaced by NICE guideline CG121].

    Technology appraisal guidance
    Published
    26 June 2001

  6. Smoking: harm reduction (QS92)

    This quality standard has been updated and replaced by NICE quality standard 207.

    Quality standard
    Published
    2 July 2015

  7. Obesity in children and young people: prevention and lifestyle weight management programmes (QS94)

    This quality standard has been updated and replaced by NICE quality standard 212.

    Quality standard
    Published
    23 July 2015

  8. Obesity in adults: prevention and lifestyle weight management programmes (QS111)

    This quality standard has been updated and replaced by NICE quality standard 212.

    Quality standard
    Published
    19 January 2016

  9. Diabetes in adults (QS6)

    This quality standard is updated and replaced by the quality standards on type 1 diabetes in adults (QS208) and type 2 diabetes in adults (QS209).

    Quality standard
    Last updated
    18 August 2016

  10. Dementia: support in health and social care (QS1)

    This quality standard has been updated and replaced by NICE quality standard 184. 

    Quality standard
    Published
    29 June 2010

  11. Obesity: clinical assessment and management (QS127)

    This quality standard has been updated and replaced by NICE quality standard 212.

    Quality standard
    Published
    4 August 2016

  12. Smoking: supporting people to stop (QS43)

    This quality standard has been updated and replaced by NICE quality standard 207.

    Quality standard
    Last updated
    30 November 2021

  13. Glaucoma in adults (QS7)

    This quality standard has been updated and replaced by NICE quality standard 180.

    Quality standard
    Published
    30 March 2011

  14. Neonatal specialist care (QS4)

    This quality standard has been withdrawn. Specialist neonatal care is covered in the NICE quality standards for specialist neonatal respiratory care for babies born pre-term, developmental follow-up of children and young people born preterm, maternal and child nutrition and postnatal care.

    Quality standard
    Published
    7 October 2010

  15. Epilepsy in adults (QS26)

    This quality standard has been updated and replaced by NICE quality standard 211. 

    Quality standard
    Published
    28 February 2013